Selected research
Market Structure
Global Pneumococcal Polysaccharide Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Pneumococcal Polysaccharide Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Pneumococcal Polysaccharide Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Pneumococcal Polysaccharide Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Pneumococcal Polysaccharide Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Pneumococcal Polysaccharide Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Pneumococcal Polysaccharide Vaccine include Sino Biopharm, Zhifei Biological, Walvax, Merck & Co., Sinovac, Kangtai Bio, Antejin Biotechnology, AIM Bio and Sanofi Pasteur, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Pneumococcal Polysaccharide Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Pneumococcal Polysaccharide Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Pneumococcal Polysaccharide Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Pneumococcal Polysaccharide Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.
Pneumococcal Polysaccharide Vaccine Segment by Company
Sino Biopharm
Zhifei Biological
Walvax
Merck & Co.
Sinovac
Kangtai Bio
Antejin Biotechnology
AIM Bio
Sanofi Pasteur
Pfizer
Pneumococcal Polysaccharide Vaccine Segment by Type
PPSV23
PCV13
Others
Pneumococcal Polysaccharide Vaccine Segment by Application
Hospital
Centers for Disease Control and Prevention
Others
Pneumococcal Polysaccharide Vaccine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pneumococcal Polysaccharide Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Pneumococcal Polysaccharide Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pneumococcal Polysaccharide Vaccine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Pneumococcal Polysaccharide Vaccine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Pneumococcal Polysaccharide Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Pneumococcal Polysaccharide Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Pneumococcal Polysaccharide Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- PPSV23
- PCV13
- Others
Applications
- Hospital
- Centers for Disease Control and Prevention
- Others
Companies covered
- Sino Biopharm
- Zhifei Biological
- Walvax
- Merck & Co.
- Sinovac
- Kangtai Bio
- Antejin Biotechnology
- AIM Bio
- Sanofi Pasteur
- Pfizer
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Pneumococcal Polysaccharide Vaccine Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Pneumococcal Polysaccharide Vaccine Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Pneumococcal Polysaccharide Vaccine Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Pneumococcal Polysaccharide Vaccine Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Pneumococcal Polysaccharide Vaccine Market Dynamics
- 2.1 Pneumococcal Polysaccharide Vaccine Industry Trends
- 2.2 Pneumococcal Polysaccharide Vaccine Industry Drivers
- 2.3 Pneumococcal Polysaccharide Vaccine Industry Opportunities and Challenges
- 2.4 Pneumococcal Polysaccharide Vaccine Industry Restraints
3 Pneumococcal Polysaccharide Vaccine Market by Manufacturers
- 3.1 Global Pneumococcal Polysaccharide Vaccine Revenue by Manufacturers (2021-2026)
- 3.2 Global Pneumococcal Polysaccharide Vaccine Sales by Manufacturers (2021-2026)
- 3.3 Global Pneumococcal Polysaccharide Vaccine Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Pneumococcal Polysaccharide Vaccine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Pneumococcal Polysaccharide Vaccine Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Pneumococcal Polysaccharide Vaccine Manufacturers, Product Type & Application
- 3.7 Global Pneumococcal Polysaccharide Vaccine Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Pneumococcal Polysaccharide Vaccine Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Pneumococcal Polysaccharide Vaccine Players Market Share by Revenue in 2025
- 3.8.3 2025 Pneumococcal Polysaccharide Vaccine Tier 1, Tier 2, and Tier 3
4 Pneumococcal Polysaccharide Vaccine Market by Type
- 4.1 Pneumococcal Polysaccharide Vaccine Type Introduction
- 4.1.1 PPSV23
- 4.1.2 PCV13
- 4.1.3 Others
- 4.2 Global Pneumococcal Polysaccharide Vaccine Sales by Type
- 4.2.1 Global Pneumococcal Polysaccharide Vaccine Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Pneumococcal Polysaccharide Vaccine Sales by Type (2021-2032)
- 4.2.3 Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Type (2021-2032)
- 4.3 Global Pneumococcal Polysaccharide Vaccine Revenue by Type
- 4.3.1 Global Pneumococcal Polysaccharide Vaccine Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Pneumococcal Polysaccharide Vaccine Revenue by Type (2021-2032)
- 4.3.3 Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Type (2021-2032)
5 Pneumococcal Polysaccharide Vaccine Market by Application
- 5.1 Pneumococcal Polysaccharide Vaccine Application Introduction
- 5.1.1 Hospital
- 5.1.2 Centers for Disease Control and Prevention
- 5.1.3 Others
- 5.2 Global Pneumococcal Polysaccharide Vaccine Sales by Application
- 5.2.1 Global Pneumococcal Polysaccharide Vaccine Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Pneumococcal Polysaccharide Vaccine Sales by Application (2021-2032)
- 5.2.3 Global Pneumococcal Polysaccharide Vaccine Sales Market Share by Application (2021-2032)
- 5.3 Global Pneumococcal Polysaccharide Vaccine Revenue by Application
- 5.3.1 Global Pneumococcal Polysaccharide Vaccine Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Pneumococcal Polysaccharide Vaccine Revenue by Application (2021-2032)
- 5.3.3 Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Application (2021-2032)
6 Global Pneumococcal Polysaccharide Vaccine Sales by Region
- 6.1 Global Pneumococcal Polysaccharide Vaccine Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Pneumococcal Polysaccharide Vaccine Sales by Region (2021-2032)
- 6.2.1 Global Pneumococcal Polysaccharide Vaccine Sales by Region (2021-2026)
- 6.2.2 Global Pneumococcal Polysaccharide Vaccine Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Pneumococcal Polysaccharide Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Pneumococcal Polysaccharide Vaccine Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Pneumococcal Polysaccharide Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Pneumococcal Polysaccharide Vaccine Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Pneumococcal Polysaccharide Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Pneumococcal Polysaccharide Vaccine Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Pneumococcal Polysaccharide Vaccine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Pneumococcal Polysaccharide Vaccine Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Pneumococcal Polysaccharide Vaccine Revenue by Region
- 7.1 Global Pneumococcal Polysaccharide Vaccine Revenue by Region
- 7.1.1 Global Pneumococcal Polysaccharide Vaccine Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Pneumococcal Polysaccharide Vaccine Revenue by Region (2021-2026)
- 7.1.3 Global Pneumococcal Polysaccharide Vaccine Revenue by Region (2027-2032)
- 7.1.4 Global Pneumococcal Polysaccharide Vaccine Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Pneumococcal Polysaccharide Vaccine Revenue (2021-2032)
- 7.2.2 North America Pneumococcal Polysaccharide Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Pneumococcal Polysaccharide Vaccine Revenue (2021-2032)
- 7.3.2 Europe Pneumococcal Polysaccharide Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Pneumococcal Polysaccharide Vaccine Revenue (2021-2032)
- 7.4.2 Asia-Pacific Pneumococcal Polysaccharide Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Pneumococcal Polysaccharide Vaccine Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Pneumococcal Polysaccharide Vaccine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Sino Biopharm
- 8.1.1 Sino Biopharm Company Information
- 8.1.2 Sino Biopharm Business Overview
- 8.1.3 Sino Biopharm Pneumococcal Polysaccharide Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Sino Biopharm Pneumococcal Polysaccharide Vaccine Product Portfolio
- 8.1.5 Sino Biopharm Recent Developments
- 8.2 Zhifei Biological
- 8.2.1 Zhifei Biological Company Information
- 8.2.2 Zhifei Biological Business Overview
- 8.2.3 Zhifei Biological Pneumococcal Polysaccharide Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Zhifei Biological Pneumococcal Polysaccharide Vaccine Product Portfolio
- 8.2.5 Zhifei Biological Recent Developments
- 8.3 Walvax
- 8.3.1 Walvax Company Information
- 8.3.2 Walvax Business Overview
- 8.3.3 Walvax Pneumococcal Polysaccharide Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Walvax Pneumococcal Polysaccharide Vaccine Product Portfolio
- 8.3.5 Walvax Recent Developments
- 8.4 Merck & Co.
- 8.4.1 Merck & Co. Company Information
- 8.4.2 Merck & Co. Business Overview
- 8.4.3 Merck & Co. Pneumococcal Polysaccharide Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Merck & Co. Pneumococcal Polysaccharide Vaccine Product Portfolio
- 8.4.5 Merck & Co. Recent Developments
- 8.5 Sinovac
- 8.5.1 Sinovac Company Information
- 8.5.2 Sinovac Business Overview
- 8.5.3 Sinovac Pneumococcal Polysaccharide Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Sinovac Pneumococcal Polysaccharide Vaccine Product Portfolio
- 8.5.5 Sinovac Recent Developments
- 8.6 Kangtai Bio
- 8.6.1 Kangtai Bio Company Information
- 8.6.2 Kangtai Bio Business Overview
- 8.6.3 Kangtai Bio Pneumococcal Polysaccharide Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Kangtai Bio Pneumococcal Polysaccharide Vaccine Product Portfolio
- 8.6.5 Kangtai Bio Recent Developments
- 8.7 Antejin Biotechnology
- 8.7.1 Antejin Biotechnology Company Information
- 8.7.2 Antejin Biotechnology Business Overview
- 8.7.3 Antejin Biotechnology Pneumococcal Polysaccharide Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Antejin Biotechnology Pneumococcal Polysaccharide Vaccine Product Portfolio
- 8.7.5 Antejin Biotechnology Recent Developments
- 8.8 AIM Bio
- 8.8.1 AIM Bio Company Information
- 8.8.2 AIM Bio Business Overview
- 8.8.3 AIM Bio Pneumococcal Polysaccharide Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 AIM Bio Pneumococcal Polysaccharide Vaccine Product Portfolio
- 8.8.5 AIM Bio Recent Developments
- 8.9 Sanofi Pasteur
- 8.9.1 Sanofi Pasteur Company Information
- 8.9.2 Sanofi Pasteur Business Overview
- 8.9.3 Sanofi Pasteur Pneumococcal Polysaccharide Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Sanofi Pasteur Pneumococcal Polysaccharide Vaccine Product Portfolio
- 8.9.5 Sanofi Pasteur Recent Developments
- 8.10 Pfizer
- 8.10.1 Pfizer Company Information
- 8.10.2 Pfizer Business Overview
- 8.10.3 Pfizer Pneumococcal Polysaccharide Vaccine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Pfizer Pneumococcal Polysaccharide Vaccine Product Portfolio
- 8.10.5 Pfizer Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Pneumococcal Polysaccharide Vaccine Value Chain Analysis
- 9.1.1 Pneumococcal Polysaccharide Vaccine Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Pneumococcal Polysaccharide Vaccine Production Mode & Process
- 9.2 Pneumococcal Polysaccharide Vaccine Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Pneumococcal Polysaccharide Vaccine Distributors
- 9.2.3 Pneumococcal Polysaccharide Vaccine Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst